Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis B virus proteins eliciting protective immunity.

A R Neurath1, B A Jameson, T Huima

  • 1New York Blood Center, New York 100021.

Microbiological Sciences
|February 1, 1987
PubMed
Summary

Current hepatitis B vaccines elicit a different immune response than natural infection recovery. Future vaccines incorporating preS and nucleoprotein core determinants may improve efficacy against hepatitis B virus.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-human immunodeficiency virus type 1 microbicide cellulose acetate 1,2-benzenedicarboxylate in a human in vitro model of vaginal inflammation.

Antimicrobial agents and chemotherapy·2004
Same author

Cellulose acetate phthalate, a common pharmaceutical excipient, inactivates HIV-1 and blocks the coreceptor binding site on the virus envelope glycoprotein gp120.

BMC infectious diseases·2001
Same author

Quantitation of cellulose acetate phthalate in biological fluids as a complex with ruthenium red.

Analytical biochemistry·2001
Same author

Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explants.

The Journal of experimental medicine·2000
Same author

Effect of a cellulose acetate phthalate topical cream on vaginal transmission of simian immunodeficiency virus in rhesus monkeys.

Antimicrobial agents and chemotherapy·2000
Same author

Rational design of cytotoxic T-cell inhibitors.

Nature biotechnology·2000

Area of Science:

  • Immunology
  • Vaccinology
  • Hepatology

Background:

  • Current hepatitis B vaccines induce an immune response that differs qualitatively from that observed during recovery from natural hepatitis B virus infection.
  • This discrepancy may stem from the underrepresentation or absence of crucial antigenic determinants in existing vaccine formulations.

Purpose of the Study:

  • To investigate the qualitative differences between vaccine-induced and natural infection-induced immune responses to hepatitis B.
  • To identify specific antigenic determinants that may be lacking in current hepatitis B vaccines.

Main Methods:

  • Comparative analysis of immune responses elicited by current hepatitis B vaccines versus natural hepatitis B virus infection recovery.
  • Identification and characterization of preS and nucleoprotein core-specific determinants.

Main Results:

  • Significant qualitative differences were observed in the immune responses generated by hepatitis B vaccines compared to natural infection recovery.
  • The absence or underrepresentation of preS- and nucleoprotein core-specific epitopes was identified as a likely cause for these disparate responses.

Conclusions:

  • The current hepatitis B vaccines may not fully replicate the breadth of the immune response seen in natural recovery.
  • Incorporating preS and nucleoprotein core determinants into future hepatitis B vaccines holds promise for enhancing their immunogenicity and efficacy.

Related Experiment Videos